Form 4: Concentra Executive Granted 60,000 Restricted Shares

Concentra Group Holdings Parent, Inc. reports an acquisition of 60,000 restricted common stock shares by Executive Vice President Jonathan P. Conser, vesting over four years.

Summary

• Jonathan P. Conser, Executive Vice President, Chief Growth & Customer Officer of Concentra Group Holdings Parent, Inc., was granted 60,000 shares of common stock.
• The transaction date for this acquisition was November 4, 2025.
• These shares were granted at a price of $0, indicating a restricted stock grant.
• The restricted stock will vest in equal annual installments over four years.
• Following this transaction, Mr. Conser beneficially owns 120,000 shares of common stock.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a key executive is generally a positive signal for executive retention and alignment of interests, though it's a routine compensation event rather than a direct operational or financial performance update.

Positives

• Grant of restricted stock to a key executive, Jonathan P. Conser, aligns management incentives with long-term shareholder value.
• The vesting schedule over four years encourages executive retention and sustained performance.

Risks

• The value of the restricted stock is tied to the future performance of Concentra Group Holdings Parent, Inc.'s common stock, exposing the executive to market fluctuations.

Future Outlook

The restricted stock grant with a four-year vesting schedule indicates a long-term commitment to the executive and an expectation of continued performance and value creation over this period.

Industry Context

Executive equity grants are a standard practice across industries, particularly in healthcare services, to incentivize leadership, align interests with shareholders, and retain talent. This grant is consistent with typical executive compensation structures.

Comparison to Industry Standards

• The grant of restricted stock with a multi-year vesting schedule is a common practice in executive compensation across publicly traded companies, comparable to similar awards at peers in the healthcare services sector.
• The $0 acquisition price is typical for restricted stock grants, which are compensation rather than open market purchases.

Corporate Governance

Related Party Transactions

• Grant of 60,000 restricted common stock shares to Jonathan P. Conser, an Executive Vice President and Chief Growth & Customer Officer of Concentra Group Holdings Parent, Inc.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of executive interests with long-term company performance and retention of key talent.
• Employees: May signal stability in executive leadership.

Next Steps

• The restricted stock will vest in equal annual installments over the next four years, starting from November 4, 2025.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event (restricted stock grant) and does not provide new information on the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It primarily indicates alignment of executive incentives with long-term shareholder value.

Keywords

Concentra Group Holdings Parent Inc, CON, Form 4, Insider Trading, Restricted Stock Grant, Executive Compensation, Jonathan P. Conser, Equity Award, Stock Vesting